New ADR reporting regulations in place in Canada
This article was originally published in SRA
Executive Summary
Canada has made changes to its regulations on adverse drug reaction reporting by pharmaceutical companies1,2. The new regulations, which came into effect on 2 March, require manufacturers to notify to the health minister when they identify any significant safety signals in their annual summary reports.